IDENTIV INC (INVE) Fundamental Analysis & Valuation

NASDAQ:INVE • US45170X2053

Current stock price

3.72 USD
+0.03 (+0.81%)
At close:
3.99 USD
+0.27 (+7.26%)
After Hours:

This INVE fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

1

1. INVE Profitability Analysis

1.1 Basic Checks

  • INVE had negative earnings in the past year.
  • INVE had a negative operating cash flow in the past year.
  • In multiple years INVE reported negative net income over the last 5 years.
  • The reported operating cash flow has been mixed in the past 5 years: INVE reported negative operating cash flow in multiple years.
INVE Yearly Net Income VS EBIT VS OCF VS FCFINVE Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 20M -20M 40M 60M

1.2 Ratios

  • INVE has a worse Return On Assets (-12.44%) than 66.94% of its industry peers.
  • With a Return On Equity value of -13.38%, INVE is not doing good in the industry: 62.90% of the companies in the same industry are doing better.
Industry RankSector Rank
ROA -12.44%
ROE -13.38%
ROIC N/A
ROA(3y)8.9%
ROA(5y)5.13%
ROE(3y)8.5%
ROE(5y)4.81%
ROIC(3y)N/A
ROIC(5y)N/A
INVE Yearly ROA, ROE, ROICINVE Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 -100 -200 -300

1.3 Margins

  • INVE's Gross Margin of 6.08% is on the low side compared to the rest of the industry. INVE is outperformed by 86.29% of its industry peers.
  • INVE's Gross Margin has declined in the last couple of years.
  • The Profit Margin and Operating Margin are not available for INVE so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 6.08%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-44.83%
GM growth 5Y-30.96%
INVE Yearly Profit, Operating, Gross MarginsINVE Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 100 -100 200

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

7

2. INVE Health Analysis

2.1 Basic Checks

  • INVE does not have a ROIC to compare to the WACC, probably because it is not profitable.
  • Compared to 1 year ago, INVE has more shares outstanding
  • The number of shares outstanding for INVE has been increased compared to 5 years ago.
  • INVE has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
INVE Yearly Shares OutstandingINVE Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 5M 10M 15M 20M
INVE Yearly Total Debt VS Total AssetsINVE Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 50M 100M 150M

2.2 Solvency

  • An Altman-Z score of 2.46 indicates that INVE is not a great score, but indicates only limited risk for bankruptcy at the moment.
  • INVE's Altman-Z score of 2.46 is in line compared to the rest of the industry. INVE outperforms 40.32% of its industry peers.
  • There is no outstanding debt for INVE. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Altman-Z 2.46
ROIC/WACCN/A
WACC9.82%
INVE Yearly LT Debt VS Equity VS FCFINVE Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 50M 100M 150M

2.3 Liquidity

  • A Current Ratio of 15.19 indicates that INVE has no problem at all paying its short term obligations.
  • The Current ratio of INVE (15.19) is better than 95.97% of its industry peers.
  • A Quick Ratio of 14.40 indicates that INVE has no problem at all paying its short term obligations.
  • INVE has a better Quick ratio (14.40) than 96.77% of its industry peers.
Industry RankSector Rank
Current Ratio 15.19
Quick Ratio 14.4
INVE Yearly Current Assets VS Current LiabilitesINVE Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 50M 100M 150M

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

4

3. INVE Growth Analysis

3.1 Past

  • The Earnings Per Share has grown by an impressive 26.42% over the past year.
  • Looking at the last year, INVE shows a very negative growth in Revenue. The Revenue has decreased by -19.32% in the last year.
  • The Revenue for INVE have been decreasing by -24.38% on average. This is quite bad
EPS 1Y (TTM)26.42%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%11.11%
Revenue 1Y (TTM)-19.32%
Revenue growth 3Y-42.48%
Revenue growth 5Y-24.38%
Sales Q2Q%-7.93%

3.2 Future

  • Based on estimates for the next years, INVE will show a quite strong growth in Earnings Per Share. The EPS will grow by 12.30% on average per year.
  • INVE is expected to show a strong growth in Revenue. In the coming years, the Revenue will grow by 88.38% yearly.
EPS Next Y16.74%
EPS Next 2Y12.3%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year22.72%
Revenue Next 2Y21.72%
Revenue Next 3Y88.38%
Revenue Next 5YN/A

3.3 Evolution

  • The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
INVE Yearly Revenue VS EstimatesINVE Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 50M 100M
INVE Yearly EPS VS EstimatesINVE Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 0 -1 -2 -3

More info and screens

Find the best growth stocksShow best growing peers

0

4. INVE Valuation Analysis

4.1 Price/Earnings Ratio

  • The Price/Earnings Ratio is negative for INVE. In the last year negative earnings were reported.
  • Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for INVE. No positive earnings are expected for the next year.
Industry RankSector Rank
PE N/A
Fwd PE N/A
INVE Price Earnings VS Forward Price EarningsINVE Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 10 20 30 40 50

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
INVE Per share dataINVE EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 2 4

4.3 Compensation for Growth

  • A more expensive valuation may be justified as INVE's earnings are expected to grow with 12.30% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y12.3%
EPS Next 3YN/A

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. INVE Dividend Analysis

5.1 Amount

  • No dividends for INVE!.
Industry RankSector Rank
Dividend Yield 0%

More info and screens

Find the best dividend stocksShow peers with best dividend

INVE Fundamentals: All Metrics, Ratios and Statistics

IDENTIV INC

NASDAQ:INVE (4/17/2026, 8:21:58 PM)

After market: 3.99 +0.27 (+7.26%)

3.72

+0.03 (+0.81%)

Chartmill FA Rating
GICS IndustryGroupTechnology Hardware & Equipment
GICS IndustryElectronic Equipment, Instruments & Components
Earnings (Last)03-12
Earnings (Next)04-30
Inst Owners55.82%
Inst Owner Change0.18%
Ins Owners1.07%
Ins Owner Change1%
Market Cap89.09M
Revenue(TTM)21.48M
Net Income(TTM)-18.83M
Analysts82.22
Price Target5.44 (46.24%)
Short Float %0.77%
Short Ratio2.08
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)19.01%
Min EPS beat(2)5.88%
Max EPS beat(2)32.13%
EPS beat(4)3
Avg EPS beat(4)12.22%
Min EPS beat(4)-3.34%
Max EPS beat(4)32.13%
EPS beat(8)4
Avg EPS beat(8)-5.97%
EPS beat(12)5
Avg EPS beat(12)-35.84%
EPS beat(16)8
Avg EPS beat(16)-24.52%
Revenue beat(2)1
Avg Revenue beat(2)4.57%
Min Revenue beat(2)-1.78%
Max Revenue beat(2)10.92%
Revenue beat(4)2
Avg Revenue beat(4)2.59%
Min Revenue beat(4)-3.11%
Max Revenue beat(4)10.92%
Revenue beat(8)4
Avg Revenue beat(8)2.58%
Revenue beat(12)4
Avg Revenue beat(12)0.12%
Revenue beat(16)5
Avg Revenue beat(16)-1.32%
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)0%
EPS NQ rev (3m)11.54%
EPS NY rev (1m)6.37%
EPS NY rev (3m)15.11%
Revenue NQ rev (1m)11.26%
Revenue NQ rev (3m)33.87%
Revenue NY rev (1m)2.52%
Revenue NY rev (3m)9.74%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 4.15
P/FCF N/A
P/OCF N/A
P/B 0.63
P/tB 0.63
EV/EBITDA N/A
EPS(TTM)-0.78
EYN/A
EPS(NY)-0.65
Fwd EYN/A
FCF(TTM)-0.33
FCFYN/A
OCF(TTM)-0.28
OCFYN/A
SpS0.9
BVpS5.87
TBVpS5.87
PEG (NY)N/A
PEG (5Y)N/A
Graham Number0 (-100%)
Profitability
Industry RankSector Rank
ROA -12.44%
ROE -13.38%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 6.08%
FCFM N/A
ROA(3y)8.9%
ROA(5y)5.13%
ROE(3y)8.5%
ROE(5y)4.81%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-44.83%
GM growth 5Y-30.96%
F-Score3
Asset Turnover0.14
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 54.69%
Cap/Sales 5.16%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 15.19
Quick Ratio 14.4
Altman-Z 2.46
F-Score3
WACC9.82%
ROIC/WACCN/A
Cap/Depr(3y)87.84%
Cap/Depr(5y)108.28%
Cap/Sales(3y)6.87%
Cap/Sales(5y)5.22%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)26.42%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%11.11%
EPS Next Y16.74%
EPS Next 2Y12.3%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-19.32%
Revenue growth 3Y-42.48%
Revenue growth 5Y-24.38%
Sales Q2Q%-7.93%
Revenue Next Year22.72%
Revenue Next 2Y21.72%
Revenue Next 3Y88.38%
Revenue Next 5YN/A
EBIT growth 1Y24.79%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year51.85%
EBIT Next 3Y43.17%
EBIT Next 5YN/A
FCF growth 1Y53.85%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y56.57%
OCF growth 3YN/A
OCF growth 5YN/A

IDENTIV INC / INVE Fundamental Analysis FAQ

Can you provide the ChartMill fundamental rating for IDENTIV INC?

ChartMill assigns a fundamental rating of 3 / 10 to INVE.


What is the valuation status of IDENTIV INC (INVE) stock?

ChartMill assigns a valuation rating of 0 / 10 to IDENTIV INC (INVE). This can be considered as Overvalued.


What is the profitability of INVE stock?

IDENTIV INC (INVE) has a profitability rating of 1 / 10.


Can you provide the financial health for INVE stock?

The financial health rating of IDENTIV INC (INVE) is 7 / 10.


What is the expected EPS growth for IDENTIV INC (INVE) stock?

The Earnings per Share (EPS) of IDENTIV INC (INVE) is expected to grow by 16.74% in the next year.